Research & Development
Academic Report
Clinical Significance of Elevated Levels of Soluble-Form Immune Checkpoint Molecules in Patients With Aggressive Adult T-Cell Leukemia-Lymphoma
| Presented by: | Shigeo Fuji1), Junya Makiyama2), Kuniko Takano3), Ilseung Choi4), Takeo Suzuki5), Chihiro Suminaka6), Mao Kuroishi6), Yosuke Iwasaki5), Hidenori Kasahara1), Yuma Tada1), Yasuhiro Shingai1), Sayako Yuda1), Takafumi Yokota1), Jun Ishikawa1) |
| 1) Department of Hematology, Osaka International Cancer Institute 2) Department of Hematology, Sasebo City General Hospital 3) Department of Medical Oncology & Hematology, Faculty of Medicine, Oita University 4) Department of Hematology and Cell Therapy, Kyushu Cancer Center 5) Medical & Scientific Affairs, Sysmex Corporation 6) Central Research Laboratories, Sysmex Corporation |
|
|
Journal:
|
eJHaem: 6(4): e70046
|
|
DOI:
|
10.1002/jha2.70046
|
- Information contained in the academic report is current as of the date of the announcement,
but may be subject to change without prior notice.